The first real-world assessment of BBV152, a COVID-19 vaccine developed in India, suggests that two vaccine doses result in 50% effectiveness against symptomatic COVID-19.
from Medindia Health News https://ift.tt/3HVqnkL
via
Mutations in Omicron variant bond with human cells far more efficiently than previous strains revealed a study led by an Indian-origin researcher. from Medindia Health News https://ift.tt/3pnMkSi via
A new study that examined the sperm quality of Belgians who got infected with COVID-19 found that the sperm quality was reduced even after weeks of recovering from coronavirus. from Medindia Health News https://ift.tt/3poffWk via
Treatment with ketamine has a short-term effect on decreasing depression and suicidal thoughts symptoms. from Medindia Health News https://ift.tt/3qpWocK via
The first real-world assessment of BBV152, a COVID-19 vaccine developed in India, suggests that two vaccine doses result in 50% effectiveness against symptomatic COVID-19.
Comments
Post a Comment